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Abstract
The aim of the present study was to examine the effects of a number of P2-purinoceptor
antagonists on degradation of adenine nucleotides by Xenopus laevis oocyte ecto-nucleotidases.
Folliculated oocytes readily metabolize all three naturally-occurring nucleotides, the order of
preferential substrates being ATP > ADP > AMP. The degradation of ATP and ADP was decreased
significantly  in  the  presence  of  several  P2X-  and  P2Y-purinoceptor  antagonists,  including
suramin, PPADS, Cibacron blue, Coomassie Brilliant blue, Evans blue, Trypan blue, Congo red,
and PIT (each compound was used at 100 μM). All these compounds inhibited the degradation of
ATP by up to 60%, whereas the hydrolysis of ADP was inhibited by Congo red and PIT by 75-
80%. In addition, DIDS (100 μM) and TNP-ATP (100 μM) selectively inhibited the breakdown of
ATP, and sodium azide (10 mM) selectively inhibited the breakdown of ADP. The enzymatic
breakdown of either ATP or ADP was unaffected by 8-pSPT (100 μM), an antagonist of P1-
purinoceptors,  or  by  oxidized  ATP  (100  μM),  an  antagonist  of  P2Z-purinoceptors.  The
degradation of AMP was prevented completely by PIT (100 μM) and inhibited significantly by
Congo red (100 μM). In conclusion, the present study shows that most of currently available
antagonists of P2-purinoceptors inhibit the enzymatic breakdown of extracellular ATP and ADP.
The inhibitory effect on ecto-nucleotidase activity should be taken into account when these
antagonists are used in pharmacological experiments.
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